Patients with ASPSCR1-TFE3 fusion achieve better response to ICI based combination therapy among TFE3-rearranged renal cell carcinoma

ABSTRACT:

SUBMITTER: Zhao J 

PROVIDER: S-EPMC11200839 | biostudies-literature | 2024 Jan

REPOSITORIES: biostudies-literature